(3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile CAS 727382-14-1 Purity >98.0% (GC) Rosuvastatin Calcium Intermediate

Short Description:

Name: (3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile 

CAS: 727382-14-1

Purity: >98.0% (GC)

Appearance: Light Yellow to Reddish Brown Liquid

Intermediate of Rosuvastatin Calcium (CAS: 147098-20-2) 

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Manufacturer Supply With High Quality, Commercial Production 
Chemical Name: (3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile 
CAS: 727382-14-1

Chemical Properties:

Chemical Name (3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile
Synonyms Rosuvastatin Calcium Intermediate
CAS Number 727382-14-1
CAT Number RF-PI1263
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H14ClNOSi
Molecular Weight 191.73
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Light Yellow to Reddish Brown Liquid
Purity / Analysis Method >98.0% (GC)
Moisture (K.F) <0.50%
Total Impurities <2.00%
Heavy Metals <20ppm
Test Standard Enterprise Standard
Usage Intermediate of Rosuvastatin Calcium (CAS: 147098-20-2)

Package & Storage:

Package: Bottle, 25kg/Barrel, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

(3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile (CAS: 727382-14-1) is used in the synthesis of statins or HMG-CoA reductase inhibitors. (3S)-4-Chloro-3-[(trimethylsilyl)oxy]butanenitrile is an intermediate of Rosuvastatin Calcium (CAS: 147098-20-2). Rosuvastatin Calcium is an anti-hyperlipidemia drug which belongs to the inhibitor of HMG-CoA reductase successfully developed by the British AstraZeneca company. Rosuvastatin Calcium is suitable for the treatment of various lipid abnormalities, including hypercholesterolemia, mixed lipid qualitative abnormalities and simple hypertriglyceridemia. Rosuvastatin Calcium is listed as the strongest and the most comprehensive statins drugs which has entered into market for lipid-lowering and adjustment.

  • Write your message here and send it to us